Clostridium difficile bacteria are major causes of healthcare associated infections, especially in the elderly or in patients treated by antibiotics. Intensive use of antibiotics can promote C. difficile expansion, leading to severe outcomes. Rapid detection of patients with Clostridium difficile infections in healthcare facilities is crucial, to isolate infected patients, provide an appropriate treatment and proceed to decontamination.
C. difficile ELITe MGB® Kit is a real-time PCR assay designed for the detection and the differentiation of Clostridium difficile toxins A and B DNA, including the hypervirulent epidemic NAP1/BI/027 strain. The assay is CE-IVD validated on stool, in combination with ELITe InGenius®, a fully automated sample-to-result solution.
Benefits
Conserved targets
Conserved regions of Toxin A (tcdA) and Toxin B (tcdB) genes and an artificial DNA sequence as an internal control
Easy-to-use
Monoreagent, ready to use
Best-in class PCR technology
ELITe MGB probes designed with Minor Groove Binder, Superbases® and Eclipse® Dark Quencher
Integrated workflow
Fully automated process for extraction, amplification and result analysis with ELITe InGenius
Eluate storage
Additional testing including multiple PCR from the same eluate, retesting or archiving
Complete HAI menu -
CRE ELITe MGB® Kit, ESBL ELITe MGB® Kit, MRSA/SA ELITe MGB® Kit and Colistin - R ELITe MGB® Kit